202 related articles for article (PubMed ID: 27463002)
1. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
Luo YQ; Wang D; Gong T; Zhu J
Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002
[TBL] [Abstract][Full Text] [Related]
2. Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis.
Duan W; Wang E; Zhang F; Wang T; You X; Qiao B
Cancer Invest; 2014 Aug; 32(7):311-20. PubMed ID: 24827594
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
[TBL] [Abstract][Full Text] [Related]
4. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.
Fu W; Zhuo ZJ; Chen YC; Zhu J; Zhao Z; Jia W; Hu JH; Fu K; Zhu SB; He J; Liu GC
Oncotarget; 2017 Feb; 8(6):9806-9822. PubMed ID: 28039461
[TBL] [Abstract][Full Text] [Related]
5. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
[TBL] [Abstract][Full Text] [Related]
6. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
7. Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.
Wang D; Xie T; Xu J; Wang H; Zeng W; Rao S; Zhou K; Pei F; Zhou Z
Sci Rep; 2016 Jul; 6():30220. PubMed ID: 27443693
[TBL] [Abstract][Full Text] [Related]
8. Association Between the NFKB1-94ins/del ATTG Polymorphism (rs28362491) and Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Chen QJ; Lai HM; Zhao L; Ma YT; Li XM; Zhai H; Zhou Y; He CH; Chen BD; Liu F; Yang YN
Genet Test Mol Biomarkers; 2016 Mar; 20(3):105-11. PubMed ID: 26799199
[TBL] [Abstract][Full Text] [Related]
9. Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.
Yang X; Li P; Tao J; Qin C; Cao Q; Gu J; Deng X; Wang J; Liu X; Wang Z; Wu B; Gu M; Lu Q; Yin C
Int J Genomics; 2014; 2014():612972. PubMed ID: 24895544
[TBL] [Abstract][Full Text] [Related]
10. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
[TBL] [Abstract][Full Text] [Related]
11. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
12. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
13. Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk.
Zhou B; Qie M; Wang Y; Yan L; Zhang Z; Liang A; Wang T; Wang X; Song Y; Zhang L
Ann Oncol; 2010 Mar; 21(3):506-511. PubMed ID: 19892748
[TBL] [Abstract][Full Text] [Related]
14. A functional haplotype of NFKB1 influence susceptibility to oral cancer: a population-based and in vitro study.
Chen F; Liu F; Yan L; Lin L; Qiu Y; Wang J; Wu J; Bao X; Hu Z; Cai L; He B
Cancer Med; 2018 May; 7(5):2211-2218. PubMed ID: 29635862
[TBL] [Abstract][Full Text] [Related]
15. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
[TBL] [Abstract][Full Text] [Related]
16. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H
Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975
[TBL] [Abstract][Full Text] [Related]
17. NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population.
Fan Y; Yu W; Ye P; Wang H; Wang Z; Meng Q; Duan Y; Liang X; An W
DNA Cell Biol; 2011 Apr; 30(4):241-5. PubMed ID: 21138333
[TBL] [Abstract][Full Text] [Related]
18. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers.
Lin SC; Liu CJ; Yeh WI; Lui MT; Chang KW; Chang CS
Cancer Lett; 2006 Nov; 243(1):47-54. PubMed ID: 16387424
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the
Chen J; Ge D; Xiong Y
Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
